- Home
- SENEA vs BME Comparison
SENEA vs BME Comparison
Compare SENEA & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENEA
- BME
- Stock Information
- Founded
- SENEA 1949
- BME 2005
- Country
- SENEA United States
- BME United States
- Employees
- SENEA N/A
- BME N/A
- Industry
- SENEA Packaged Foods
- BME Trusts Except Educational Religious and Charitable
- Sector
- SENEA Consumer Staples
- BME Finance
- Exchange
- SENEA Nasdaq
- BME Nasdaq
- Market Cap
- SENEA 573.2M
- BME 462.3M
- IPO Year
- SENEA N/A
- BME N/A
- Fundamental
- Price
- SENEA $82.54
- BME $36.00
- Analyst Decision
- SENEA
- BME
- Analyst Count
- SENEA 0
- BME 0
- Target Price
- SENEA N/A
- BME N/A
- AVG Volume (30 Days)
- SENEA 35.1K
- BME 34.0K
- Earning Date
- SENEA 06-12-2025
- BME 01-01-0001
- Dividend Yield
- SENEA N/A
- BME 6.26%
- EPS Growth
- SENEA 25.61
- BME N/A
- EPS
- SENEA 5.45
- BME 1.44
- Revenue
- SENEA $1,541,031,000.00
- BME N/A
- Revenue This Year
- SENEA N/A
- BME N/A
- Revenue Next Year
- SENEA N/A
- BME N/A
- P/E Ratio
- SENEA $15.15
- BME $28.37
- Revenue Growth
- SENEA 4.00
- BME N/A
- 52 Week Low
- SENEA $51.79
- BME $35.53
- 52 Week High
- SENEA $92.00
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- SENEA 42.15
- BME 39.05
- Support Level
- SENEA $82.00
- BME $35.78
- Resistance Level
- SENEA $85.20
- BME $36.65
- Average True Range (ATR)
- SENEA 3.27
- BME 1.11
- MACD
- SENEA -0.66
- BME -0.03
- Stochastic Oscillator
- SENEA 14.00
- BME 38.72
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.